| Title : Multitarget drugs as potential therapeutic agents for alzheimer's disease. A new family of 5-substituted indazole derivatives as cholinergic and BACE1 inhibitors - Gonzalez-Naranjo_2022_J.Enzyme.Inhib.Med.Chem_37_2348 |
| Author(s) : Gonzalez-Naranjo P , Perez C , Gonzalez-Sanchez M , Gironda-Martinez A , Ulzurrun E , Bartolome F , Rubio-Fernandez M , Martin-Requero A , Campillo NE , Paez JA |
| Ref : J Enzyme Inhib Med Chem , 37 :2348 , 2022 |
| Abstract : Gonzalez-Naranjo_2022_J.Enzyme.Inhib.Med.Chem_37_2348 |
| ESTHER : Gonzalez-Naranjo_2022_J.Enzyme.Inhib.Med.Chem_37_2348 |
| PubMedSearch : Gonzalez-Naranjo_2022_J.Enzyme.Inhib.Med.Chem_37_2348 |
| PubMedID: 36050834 |
Gonzalez-Naranjo P, Perez C, Gonzalez-Sanchez M, Gironda-Martinez A, Ulzurrun E, Bartolome F, Rubio-Fernandez M, Martin-Requero A, Campillo NE, Paez JA (2022)
Multitarget drugs as potential therapeutic agents for alzheimer's disease. A new family of 5-substituted indazole derivatives as cholinergic and BACE1 inhibitors
J Enzyme Inhib Med Chem
37 :2348
Gonzalez-Naranjo P, Perez C, Gonzalez-Sanchez M, Gironda-Martinez A, Ulzurrun E, Bartolome F, Rubio-Fernandez M, Martin-Requero A, Campillo NE, Paez JA (2022)
J Enzyme Inhib Med Chem
37 :2348